Healthcare Investing Summit

How is Covid-19 influencing LP allocations toward healthcare? How do managers think about value creation in a post-Covid environment?

Join PrivateEquityWire as we explore the latest trends and themes in the fast-changing world of healthcare investing.


Free for LPs. Prices starting at £145 for GPs, and £495 for service providers.

17th March 2021

THE WORLD HAS CHANGED.

WHY THIS EVENT?

The global pandemic has sharpened the focus of GPs and LPs on healthcare investing, creating an array of new opportunities and accelerating many themes and trends throughout this dynamic and diverse sector.


Where are the best opportunities for value creation, in the US and Europe? What areas of healthcare look most attractive? Where are the biggest changes and innovations? What are GPs and LPs looking for now? Which investment approaches work best? How is the deal landscape evolving?


Private Equity Wire’s PEWlive Healthcare Investing Summit is designed to give GPs, LPs, deal-makers, advisers and operating partners new insights into the key themes, trends, innovations and technologies shaping the world of healthcare investment, now and in the future.


Join us on 17 March to explore the most exciting opportunities for fund managers and investors in the fast-changing healthcare sector.

REGISTER NOW

AGENDA

COVID-19 CHANGED EVERYTHING. OR HAS IT?

EVENT DAY | 17 March

EVENT DAY | 17 March 2021

PANEL 1

Value creation in Europe’s Healthcare sector

  • Value creation: How do managers think about value creation in a post-Covid environment? How do they measure it, and what are one or two of the most important metrics they look for in a target technology company?
  • Value protection: Easy to protect value in a benign environment, but how did managers approach risk management in light of market volatility in 2020? And how will this be informing their portfolio management activities over the coming years?
  • Deal sourcing: What types of healthcare opportunities are managers looking for across Europe and what do PPMs look like relative to the US and Asia? Does Europe still offer good ‘value’?
  • Risk management considerations: Both in terms of regulatory risk and post-acquisition management team risk i.e. conflicts of interest.Investor return expectations: Is there a disconnect between GPs and LPs when it comes to return expectations from healthcare-focused funds?

PRESENTATION

Agenda coming soon

James Williams // Editor in Chief, PrivateEquityWire

OPENING ADDRESS

1:50 PM

2:00 PM

2:50 PM

SPEAKERS:

Sam Gray, Managing Partner, Apposite Capital

Joe Stringer, Partner, Octopus Ventures

Matthieu Dederichs, Principal, GHO Capital Partners LLP

PANEL 2

Driving change in the US Healthcare sector

  • Assessing the opportunity set within North America’s healthcare sector – what areas of healthcare look attractive, from a valuation perspective?
  • What are the different approaches mid-market buyout funds are taking to prosecute deals, relative to large/megacap buyout funds? And what creative solutions are GPs engineering (i.e. preferred equity, debt financing, growth capital financing)?
  • How might Covid-19 impact the deal landscape within US healthcare over the coming years? Do you expect even more competition to complete deals?
  • How important a role are operating partners playing - including academic experts & scientific advisors – in driving value within the portfolio? And how are GPs measuring the ‘value’ they bring?

PRESENTATION

Agenda coming soon

3:10 PM

4:00 PM

SPEAKERS:

Charles D. Kennedy MD,  Managing Partner, Blue Ox Healthcare Partners

Stephen McKenna, Managing Partner, Consonance Capital Partners

Jim Pieri, Managing Partner & CIO, Assured Healthcare Partners

Harry Eichelberger, Founder and Managing Partner, Archimedes Health Investors

PANEL 3

Investor insights on Healthcare investing

  • What are investors’ views on healthcare investment opportunities – how highly do they rank this sector, relative to technology, energy, retail etc.?
  • What are investors focusing on, in terms of the type of GP they are willing to back – is there more emphasis on sector specialists versus generalists, mid-cap versus large-cap, US versus Europe?
  • Any investments, including co-investments, that have worked particularly well in recent times that you can discuss anecdotally?
  • What sort of information do you look for from GPs, to best understand the value being created in your healthcare investments?
  • Do you anticipate healthcare becoming even more important in your PE investing bucket, thematically, as telemedicine gains momentum in the US, and technology supports even greater innovation?

4:20 PM

EVENT CLOSES

NETWORKING

Dedicated networking time

5:10 PM

5:40 PM

SPEAKERS:

Alistair Watson, Senior Investment Director, Private Equity, Aberdeen Standard Investments

Jamie Hayford, Vice President, Pantheon

Sandra Ferri, Head of Life Sciences Investments, European Investment Fund

Brian Gimotty, Managing Director Investments, UAW Retiree Medical Benefits Trust

Samarth Chandra, General Partner, Enhanced Healthcare Partners


PANEL 3

Investor insights on Healthcare investing

  • What are investors’ views on healthcare investment opportunities – how highly do they rank this sector, relative to technology, energy, retail etc.?
  • What are investors focusing on, in terms of the type of GP they are willing to back – is there more emphasis on sector specialists versus generalists, mid-cap versus large-cap, US versus Europe?
  • Any investments, including co-investments, that have worked particularly well in recent times that you can discuss anecdotally?
  • What sort of information do you look for from GPs, to best understand the value being created in your healthcare investments?
  • Do you anticipate healthcare becoming even more important in your PE investing bucket, thematically, as telemedicine gains momentum in the US, and technology supports even greater innovation?

4:20 PM

EVENT CLOSES

NETWORKING

Dedicated networking time

5:10 PM

5:40 PM

SPEAKERS:

Speaker, Job Title, Company

Speaker, Job Title, Company

Speaker, Job Title, Company


SPEAKERS

Interested in speaking at this event, or nominating a colleague?


Get in touch.

Managing Partner at Apposite Capital

Sam Gray

James Williams

Managing Editor at Private Equity Wire

Managing Partner at Blue Ox Blue Ox Healthcare Partners

Charles D. Kennedy MD

Senior Investment Director, Private Equity at Aberdeen Standard Investments

Alistair Watson

Stephen McKenna

Managing Partner at Consonance Capital Partners

Jim Pieri

Managing Partner & CIO at Assured Healthcare Partners

Vice President at Pantheon

Jamie Hayford

Sandra Ferri

Head of Life Sciences Investments at European Investment Fund

Harry Eichelberger

Founder and Managing Partner at Archimedes Health Investors

Partner at Octopus Ventures

Joe Stringer

Brian Gimotty

Managing Director Investments, UAW Retiree Medical Benefits Trust

Matthieu Dederichs

General Partner at Enhanced Healthcare Partners

Samarth Chandra

SPONSORSHIP

Launched in 2007, Private Equity Wire has evolved organically to become one of the industry’s leading voices on key trends and developments shaping the industry.


At a time when LPs need more insight than ever on how and why they should allocate to PE funds, PE Wire has the skillset and toolset to develop authoritative content for clients that cuts through the noise.


With our consultant-driven approach, and commitment to the highest editorial standards, our mission statement is simple: to deliver actionable insights that clients can measure.


Our last event received 550+ registrations, and saw 280+ qualified GPs in attendance.

See how we can put your brand front-and-center.

Value creation. Deal sourcing. Mid-market VS large/megacap buyout fund performance.

COVID-19 changed healthcare investing.

PRE-REGISTER NOW

The important question is how and why.